Abstract:In this study, we developed a multilayer microfluidic device to simulate nephron, which was formed by "glomerulus", "Bowman's capsule", "proximal tubular lumen" and "peritubular capillary". In this microdevice, artificial renal blood flow was circulating and glomerular filtrate flow was single passing through, mimicking the behavior of a nephron. In this dynamic artificial nephron, we observed typical renal physiology, including the glomerular size-selective barrier, glomerular basement membrane charge-selective barrier, glucose reabsorption and para-aminohippuric acid secretion. To demonstrate the capability of our microdevice, we used it to investigate the pathophysiology of drug-induced acute kidney injury (AKI) and give assessment of drug-induced nephrotoxicity, with cisplatin and doxorubicin as model drugs. In the experiment, we loaded the doxorubicin or cisplatin in the "renal blood flow", recorded the injury of primary glomerular endothelial cells, podocytes, tubular epithelial cells and peritubular endothelial cells by fluorescence imaging, and identified the time-dependence, dose-dependence and the death order of four types of renal cells. Then by measuring multiple biomarkers, including E-cadherin, VEGF, VCAM-1, Nephrin, and ZO-1, we studied the mechanism of cell injuries caused by doxorubicin or cisplatin. Also, we investigated the effect of BSA in the "renal blood flow" on doxorubicin-or-cisplatin-induced nephrotoxicity, and found that BSA enhanced the tight junctions between cells and eased cisplatin-induced nephrotoxicity. In addition, we compared the nephron model and traditional tubule models for assessment of drug-induced nephrotoxicity. And it can be inferred that our biomimetic microdevice simulated the complex, dynamic microenvironment of nephron, yielded abundant information about drug-induced-AKI at the preclinical stage, boosted the drug safety evaluation, and provided a reliable reference for clinical therapy.

Examination of the emerging role of transporters in the assessment of nephrotoxicity

Research progress in toxic effects of antitumor drugs based on drug transporter

Is the Human Model RPTEC/TERT1 a Relevant Model for Assessing Renal Drug Efflux?

The renal damage and mechanisms relevant to antitumoral drugs

Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking

In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery

The System Profile of Renal Drug Transporters in Tubulointerstitial Fibrosis Model and Consequent Effect on Pharmacokinetics

Xenobiotic transporters: ascribing function from gene knockout and mutation studies.

Three-dimensional Culture of Hepatocytes for Prediction of Drug-Induced Hepatotoxicity

The Role of the Kidney in Drug Elimination: Transport, Metabolism, and the Impact of Kidney Disease on Drug Clearance

Development of novel tools for the in vitro investigation of drug-induced liver injury

The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives

The Physiological Role of Drug Transporters

Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective

Changes of Renal Transporters in the Kinetic Process of VCM-induced Nephrotoxicity in Mice.

Studying the right transporter at the right time: an in vitro strategy for assessing drug-drug interaction risk during drug discovery and development

A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity

Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics

Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance

A murine ex vivo 3D kidney proximal tubule model predicts clinical drug-induced nephrotoxicity

Perspective on the Application of Microphysiological Systems to Drug Transporter Studies